OBJECTIVE: In order to evaluate the presence of treatment emergent suicidal ideation (SI), it becomes necessary to identify those patients with SI at the onset of treatment. The purpose of this report is to identify sociodemographic and clinical features that are associated with SI in major depressive disorder (MDD) patients prior to treatment with a selective serotonin reuptake inhibitor. METHOD: This multisite study enrolled 265 out-patients with non-psychotic MDD. Sociodemographic and clinical features of participants with and without SI were compared post hoc. RESULTS: Social phobia, bulimia nervosa, number of past depressive episodes, and race were independently associated with SI by one or more SI measure. CONCLUSION: Concurrent social phobia and bulimia nervosa may be potential risk factors for SI in patients with non-psychotic MDD. Additionally, patients with more than one past depressive episode may also be at increased risk of SI.
OBJECTIVE: In order to evaluate the presence of treatment emergent suicidal ideation (SI), it becomes necessary to identify those patients with SI at the onset of treatment. The purpose of this report is to identify sociodemographic and clinical features that are associated with SI in major depressive disorder (MDD) patients prior to treatment with a selective serotonin reuptake inhibitor. METHOD: This multisite study enrolled 265 out-patients with non-psychotic MDD. Sociodemographic and clinical features of participants with and without SI were compared post hoc. RESULTS:Social phobia, bulimia nervosa, number of past depressive episodes, and race were independently associated with SI by one or more SI measure. CONCLUSION: Concurrent social phobia and bulimia nervosa may be potential risk factors for SI in patients with non-psychotic MDD. Additionally, patients with more than one past depressive episode may also be at increased risk of SI.
Authors: Jay C Fournier; Jill M Cyranowski; Paola Rucci; Giovanni B Cassano; Ellen Frank Journal: J Psychiatr Res Date: 2012-07-05 Impact factor: 4.791
Authors: Michael J Ostacher; Andrew A Nierenberg; Dustin Rabideau; Noreen A Reilly-Harrington; Louisa G Sylvia; Alexandra K Gold; Leah W Shesler; Terence A Ketter; Charles L Bowden; Joseph R Calabrese; Edward S Friedman; Dan V Iosifescu; Michael E Thase; Andrew C Leon; Madhukar H Trivedi Journal: J Psychiatr Res Date: 2015-10-09 Impact factor: 4.791
Authors: Joseph M Trombello; Michael O Killian; Bruce D Grannemann; Augustus John Rush; Taryn L Mayes; Ramin V Parsey; Melvin McInnis; Manish K Jha; Aasia Ali; Patrick J McGrath; Phil Adams; Maria A Oquendo; Myrna M Weissman; Thomas J Carmody; Madhukar H Trivedi Journal: J Psychopharmacol Date: 2019-01-17 Impact factor: 4.153
Authors: Markus Dold; Lucie Bartova; Gernot Fugger; Alexander Kautzky; Daniel Souery; Julien Mendlewicz; George N Papadimitriou; Dimitris Dikeos; Panagiotis Ferentinos; Stefano Porcelli; Alessandro Serretti; Joseph Zohar; Stuart Montgomery; Siegfried Kasper Journal: Int J Neuropsychopharmacol Date: 2018-06-01 Impact factor: 5.176